Joël Shapiro

5.4k total citations
38 papers, 1.2k citations indexed

About

Joël Shapiro is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Joël Shapiro has authored 38 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Surgery, 19 papers in Pulmonary and Respiratory Medicine and 13 papers in Oncology. Recurrent topics in Joël Shapiro's work include Esophageal Cancer Research and Treatment (14 papers), Gastric Cancer Management and Outcomes (14 papers) and Pancreatic and Hepatic Oncology Research (6 papers). Joël Shapiro is often cited by papers focused on Esophageal Cancer Research and Treatment (14 papers), Gastric Cancer Management and Outcomes (14 papers) and Pancreatic and Hepatic Oncology Research (6 papers). Joël Shapiro collaborates with scholars based in Netherlands, United States and Australia. Joël Shapiro's co-authors include J. Jan B. van Lanschot, Bas P. L. Wijnhoven, Ewout W. Steyerberg, Ate van der Gaast, Bas P. L. Wijnhoven, Pieter van Hagen, John R. Goldblum, Mark I. van Berge Henegouwen, Robert E. Petras and Katharina Biermann and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Journal of Neuroscience.

In The Last Decade

Joël Shapiro

37 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joël Shapiro Netherlands 20 669 528 232 176 124 38 1.2k
Maiko Takeda Japan 20 266 0.4× 272 0.5× 251 1.1× 176 1.0× 184 1.5× 88 1.0k
Davide Giordano Italy 15 460 0.7× 145 0.3× 97 0.4× 132 0.8× 56 0.5× 43 942
Paolo Tini Italy 19 196 0.3× 318 0.6× 222 1.0× 267 1.5× 17 0.1× 57 1.1k
Stephanie Schneider Germany 19 198 0.3× 70 0.1× 378 1.6× 408 2.3× 106 0.9× 53 1.4k
Robert Hurford United Kingdom 18 196 0.3× 248 0.5× 448 1.9× 475 2.7× 36 0.3× 25 1.4k
William Sterlacci Germany 21 173 0.3× 490 0.9× 520 2.2× 284 1.6× 36 0.3× 64 1.3k
Veer Singh Mehta India 18 294 0.4× 183 0.3× 106 0.5× 206 1.2× 66 0.5× 44 1.0k
Yoshihisa Fukushima Japan 15 150 0.2× 98 0.2× 169 0.7× 148 0.8× 81 0.7× 80 733
Taiji Tohyama Japan 12 200 0.3× 110 0.2× 161 0.7× 236 1.3× 50 0.4× 37 732
Farhad Abtahian United States 15 363 0.5× 125 0.2× 340 1.5× 378 2.1× 192 1.5× 39 1.4k

Countries citing papers authored by Joël Shapiro

Since Specialization
Citations

This map shows the geographic impact of Joël Shapiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joël Shapiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joël Shapiro more than expected).

Fields of papers citing papers by Joël Shapiro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joël Shapiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joël Shapiro. The network helps show where Joël Shapiro may publish in the future.

Co-authorship network of co-authors of Joël Shapiro

This figure shows the co-authorship network connecting the top 25 collaborators of Joël Shapiro. A scholar is included among the top collaborators of Joël Shapiro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joël Shapiro. Joël Shapiro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shapiro, Joël, et al.. (2020). Massive splenomegaly in hairy cell leukemia causing urinary retention. SHILAP Revista de lepidopterología. 9(2). 1027–1028. 2 indexed citations
2.
Hussain, Syed Ather, et al.. (2020). Metastatic Lung Adenocarcinoma With Occult Involvement of Gluteal Muscles as the Sole Site of Distant Metastases. Cureus. 12(8). e9826–e9826. 2 indexed citations
3.
Shapiro, Joël, et al.. (2018). Laparoscopic Rectovaginopexy for Neorectal Prolapse After Transanal Total Mesorectal Excision. Diseases of the Colon & Rectum. 61(2). 260–260. 1 indexed citations
4.
Noordman, Bo Jan, Mathilde G. E. Verdam, Sjoerd M. Lagarde, et al.. (2017). Impact of neoadjuvant chemoradiotherapy on health-related quality of life in long-term survivors of esophageal or junctional cancer: results from the randomized CROSS trial. Annals of Oncology. 29(2). 445–451. 51 indexed citations
5.
Biermann, Katharina, Joël Shapiro, Bas P. L. Wijnhoven, et al.. (2016). P53 and SOX2 Protein Expression Predicts Esophageal Adenocarcinoma in Response to Neoadjuvant Chemoradiotherapy. Annals of Surgery. 265(2). 347–355. 8 indexed citations
6.
Diakos, Connie I., Val Gebski, Sidney Kam‐Hung Yip, et al.. (2016). Is the derived neutrophil to lymphocyte ratio (dNLR) an independent prognostic marker in patients with metastatic colorectal cancer (mCRC)? Analysis of the CO.17 and CO.20 studies. Annals of Oncology. 27. vi196–vi196. 2 indexed citations
7.
Shapiro, Joël, Katharina Biermann, David van Klaveren, et al.. (2016). Prognostic Value of Pretreatment Pathological Tumor Extent in Patients Treated With Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal or Junctional Cancer. Annals of Surgery. 265(2). 356–362. 29 indexed citations
8.
Noordman, Bo Jan, Joël Shapiro, Manon C.W. Spaander, et al.. (2015). Accuracy of Detecting Residual Disease After Cross Neoadjuvant Chemoradiotherapy for Esophageal Cancer (preSANO Trial): Rationale and Protocol. SHILAP Revista de lepidopterología. 4(2). e79–e79. 57 indexed citations
9.
Nieboer, Daan, Joël Shapiro, Katharina Biermann, et al.. (2015). Nomogram for predicting pathologically complete response after neoadjuvant chemoradiotherapy for oesophageal cancer. Radiotherapy and Oncology. 115(3). 392–398. 30 indexed citations
10.
Shapiro, Joël, Pieter van Hagen, Hester F. Lingsma, et al.. (2014). Prolonged Time to Surgery After Neoadjuvant Chemoradiotherapy Increases Histopathological Response Without Affecting Survival in Patients With Esophageal or Junctional Cancer. Annals of Surgery. 260(5). 807–814. 61 indexed citations
11.
Shapiro, Joël, Caspar W. N. Looman, Pieter van Hagen, et al.. (2014). Lymph Node Retrieval During Esophagectomy With and Without Neoadjuvant Chemoradiotherapy. Annals of Surgery. 260(5). 786–793. 119 indexed citations
12.
Shapiro, Joël, Fiebo J.W. ten Kate, Pieter van Hagen, et al.. (2013). Residual Esophageal Cancer after Neoadjuvant Chemoradiotherapy Frequently Involves the Mucosa and Submucosa. Annals of Surgery. 258(5). 678–689. 55 indexed citations
13.
Ong, Chin‐Ann Johnny, Joël Shapiro, Katie S. Nason, et al.. (2013). Three-Gene Immunohistochemical Panel Adds to Clinical Staging Algorithms to Predict Prognosis for Patients With Esophageal Adenocarcinoma. Journal of Clinical Oncology. 31(12). 1576–1582. 63 indexed citations
14.
Jongen, Joost L.M., Sebastiaan K. E. Koekkoek, Joël Shapiro, et al.. (2010). Autofluorescent Flavoprotein Imaging of Spinal Nociceptive Activity. Journal of Neuroscience. 30(11). 4081–4087. 9 indexed citations
15.
Bosman, Laurens W. J., Sebastiaan K. E. Koekkoek, Joël Shapiro, et al.. (2010). Encoding of whisker input by cerebellar Purkinje cells. The Journal of Physiology. 588(19). 3757–3783. 83 indexed citations
16.
Goldstein, Daniel A., Guy van Hazel, Craig Underhill, et al.. (2004). Combined modality therapy for pancreatic carcinoma - An Australian Pancreatic Cancer Group study of the addition of gemcitabine to concurrent infusional 5-fluorouracil and 3D conformal radiotherapy. Journal of Clinical Oncology. 22(14_suppl). 4100–4100. 1 indexed citations
17.
Shapiro, Joël, et al.. (2003). Actinomycosis Abscess of the Thyroid Gland. The Laryngoscope. 113(12). 2108–2111. 14 indexed citations
18.
Frater, John L., Jeffrey Hammel, Joël Shapiro, et al.. (2001). Typical and Atypical Chronic Lymphocytic Leukemia Differ Clinically and Immunophenotypically. American Journal of Clinical Pathology. 116(5). 655–664. 44 indexed citations
19.
Shapiro, Joël, et al.. (1999). CD5−B-Cell Lymphoproliferative Disorders Presenting in Blood and Bone Marrow: A Clinicopathologic Study of 40 Patients. American Journal of Clinical Pathology. 111(4). 477–487. 23 indexed citations
20.
Shapiro, Joël, John R. Goldblum, & Robert E. Petras. (1996). A Clinicopathologic Study of 42 Patients with Granulomatous Gastritis. The American Journal of Surgical Pathology. 20(4). 462–470. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maiko Takeda Breakdown of academic impact, for papers by Davide Giordano Breakdown of academic impact, for papers by Paolo Tini Breakdown of academic impact, for papers by Stephanie Schneider Breakdown of academic impact, for papers by Robert Hurford Breakdown of academic impact, for papers by William Sterlacci Breakdown of academic impact, for papers by Veer Singh Mehta Breakdown of academic impact, for papers by Yoshihisa Fukushima Breakdown of academic impact, for papers by Taiji Tohyama Breakdown of academic impact, for papers by Farhad Abtahian
Rankless by CCL
2026